Higher-Dose Ocrelizumab Shows No Added Benefit vs Approved Dose in MS
GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes
Sleep Disruptions Contribute to Likelihood of Dry Eye Syndrome
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
